Total Payments
$1.1M
2024 Payments
$342,565
Companies
55
Transactions
2,254
Medicare Patients
16,730
Medicare Billing
$1.8M
Payment Breakdown by Category
Other$879,620 (77.9%)
Consulting$114,272 (10.1%)
Travel$71,536 (6.3%)
Food & Beverage$51,538 (4.6%)
Research$11,939 (1.1%)
Education$622.50 (0.1%)
Gifts$4.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $833,412 | 301 | 73.8% |
| Consulting Fee | $114,272 | 45 | 10.1% |
| Travel and Lodging | $71,536 | 397 | 6.3% |
| Food and Beverage | $51,538 | 1,468 | 4.6% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $32,100 | 8 | 2.8% |
| Honoraria | $14,108 | 8 | 1.2% |
| Unspecified | $11,939 | 10 | 1.1% |
| Education | $622.50 | 15 | 0.1% |
| Gift | $4.00 | 2 | 0.0% |
Payments by Type
General
$1.1M
2,244 transactions
Research
$11,939
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $180,216 | 331 | $0 (2024) |
| ABBVIE INC. | $150,801 | 344 | $0 (2024) |
| Janssen Biotech, Inc. | $118,290 | 148 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $100,689 | 181 | $0 (2024) |
| GENZYME CORPORATION | $87,330 | 129 | $0 (2024) |
| UCB, Inc. | $80,280 | 151 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $54,699 | 48 | $0 (2024) |
| Amgen Inc. | $51,952 | 97 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $46,637 | 81 | $0 (2024) |
| Celgene Corporation | $42,401 | 72 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $342,565 | 525 | Janssen Biotech, Inc. ($80,990) |
| 2023 | $144,846 | 331 | Janssen Biotech, Inc. ($34,414) |
| 2022 | $158,113 | 275 | Janssen Scientific Affairs, LLC ($54,074) |
| 2021 | $46,477 | 150 | AbbVie Inc. ($19,820) |
| 2020 | $41,053 | 106 | AbbVie Inc. ($13,306) |
| 2019 | $111,049 | 264 | Novartis Pharmaceuticals Corporation ($53,999) |
| 2018 | $139,828 | 306 | Novartis Pharmaceuticals Corporation ($54,041) |
| 2017 | $145,600 | 297 | Novartis Pharmaceuticals Corporation ($53,421) |
All Payment Transactions
2,254 individual payment records from CMS Open Payments — Page 1 of 91
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,200.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,588.00 | General |
| Category: Immunology | ||||||
| 12/18/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $28.87 | General |
| Category: Dermatology | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: Inflammation | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $113.28 | General |
| Category: Immunology | ||||||
| 12/11/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $88.48 | General |
| Category: Immunology | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Immunology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.70 | General |
| Category: DERMATOLOGY | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | REYATAZ (Drug) | Food and Beverage | Cash or cash equivalent | $9.55 | General |
| Category: Virology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | REYATAZ (Drug) | Food and Beverage | Cash or cash equivalent | $1.19 | General |
| Category: Virology | ||||||
| 12/06/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $24.31 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 12/04/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Dermatology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $3.26 | General |
| Category: Dermatology | ||||||
| 12/03/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $34.91 | General |
| Category: Immunology | ||||||
| 12/03/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $2.45 | General |
| Category: DERMATOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: IMMUNOLOGY | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,500.00 | General |
| Category: Immunology | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,000.00 | General |
| Category: Immunology | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $35.11 | General |
| Category: Immunology | ||||||
| 11/29/2024 | UCB, Inc. | Bimzelx (Biological) | Travel and Lodging | Cash or cash equivalent | $22.91 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Multi-Center, Randomized, Double-Blind, Vehicle-Controlled, 2-Arm, Parallel Group Comparison Study Comparing the Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris | Valeant Pharmaceuticals North America LLC | $7,620 | 3 |
| A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $3,784 | 3 |
| CLOU064A2301,CLOU064A2302 | Novartis Pharmaceuticals Corporation | $324.09 | 1 |
| A MULTICENTER, OPEN-LABEL, PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF BARICITINIB IN ADULT PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS | Eli Lilly and Company | $210.17 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 37 | 4,221 | 8,056 | $1.4M | $435,387 |
| 2022 | 41 | 4,186 | 8,512 | $1.5M | $473,293 |
| 2021 | 41 | 4,341 | 8,473 | $1.6M | $503,906 |
| 2020 | 40 | 3,982 | 7,683 | $1.3M | $425,702 |
Total Patients
16,730
Total Services
32,724
Medicare Billing
$1.8M
Procedure Codes
159
All Medicare Procedures & Services
159 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 1,022 | 1,875 | $364,770 | $120,482 | 33.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 436 | 601 | $131,335 | $39,173 | 29.8% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 108 | 128 | $84,432 | $31,755 | 37.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 298 | 393 | $95,259 | $31,390 | 33.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 522 | 823 | $119,025 | $31,159 | 26.2% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2023 | 15 | 215 | $53,140 | $19,980 | 37.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 164 | $44,995 | $15,186 | 33.8% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 107 | 149 | $47,356 | $15,001 | 31.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 163 | 163 | $40,048 | $12,184 | 30.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 28 | 31 | $31,973 | $11,992 | 37.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 381 | 2,216 | $31,010 | $11,498 | 37.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 69 | 90 | $34,920 | $11,395 | 32.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 216 | 260 | $31,648 | $11,033 | 34.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 148 | 260 | $28,193 | $10,692 | 37.9% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 64 | 73 | $38,844 | $7,477 | 19.2% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 44 | 48 | $28,072 | $5,752 | 20.5% |
| 17281 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 29 | 37 | $14,459 | $4,959 | 34.3% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 30 | 33 | $20,247 | $4,113 | 20.3% |
| 12052 | Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm | Office | 2023 | 14 | 15 | $10,363 | $3,804 | 36.7% |
| 12042 | Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm | Office | 2023 | 15 | 15 | $10,108 | $3,642 | 36.0% |
| 17271 | Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm | Office | 2023 | 26 | 31 | $11,208 | $3,382 | 30.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 25 | 29 | $10,627 | $3,319 | 31.2% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 29 | 32 | $8,683 | $3,163 | 36.4% |
| 17282 | Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 14 | 17 | $7,611 | $2,758 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $7,596 | $2,584 | 34.0% |
About Dr. Robert Snyder, MD
Dr. Robert Snyder, MD is a Dermatology healthcare provider based in Pembroke Pines, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1447200845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Snyder, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $342,565 received in 2024. These payments were reported across 2,254 transactions from 55 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($833,412).
As a Medicare-enrolled provider, Snyder has provided services to 16,730 Medicare beneficiaries, totaling 32,724 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 159 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Pembroke Pines, FL
- Active Since 05/10/2006
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1447200845
Products in Payments
- TREMFYA (Drug) $170,377
- COSENTYX (Biological) $165,470
- DUPIXENT (Biological) $97,475
- SKYRIZI (Biological) $85,261
- Otezla (Drug) $76,536
- Bimzelx (Biological) $71,343
- DUPIXENT DUPILUMAB INJECTION (Biological) $58,060
- RINVOQ (Biological) $57,016
- ILUMYA (Biological) $42,947
- CIBINQO (Drug) $39,464
- SILIQ (Drug) $36,854
- Sotyktu (Drug) $27,988
- ADBRY (Biological) $27,199
- SPEVIGO (Drug) $17,444
- DUPIXENT (Drug) $17,021
- ATOPIC DERMATITIS - DISEASE (Drug) $12,417
- Enbrel (Biological) $11,202
- SIVEXTRO (Drug) $7,936
- COSENTYX (Drug) $7,540
- Humira (Biological) $6,098
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Pembroke Pines
Dr. Quang Le, Md, MD
Dermatology — Payments: $22,075
Dermatology $22,075
Dr. Phi-Van Le, Md, MD
Dermatology — Payments: $9,851
Dermatology $9,851
Vassiliki Papastavros
Dermatology — Payments: $7,476
Dermatology $7,476
Nicky Gazy
Dermatology — Payments: $6,365
Dermatology $6,365
Dr. Jay Gottlieb, Do, DO
Dermatology — Payments: $4,342
Dermatology $4,342
Annyella Douglas
Dermatology — Payments: $4,172
Dermatology $4,172